In the field of neoantigen therapy, NeoCura has built a unique Drug Screening & Validation platform, which, at molecular and cellular levels, can accurately and rapidly identify the neoantigen combination(s) with the best effect from a variety of predicted neoantigens. Based on this platform, an efficacy assessment system is established accordingly to accurately assess the clinical effect of the neoantigen therapy in patients.